OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.

Biotechnology

OncoNano Medicine

OncoNano Medicine's headquarters in Southlake, TX, United States

Kathy Rath

Matthew Head

Angie Haar

Tian Zhao

Kartik Krishnan

Ruolan Han

Bhargavi Allu

George Pickard

Coby White

Ashley Campbell

Jason Miller

Melissa Paoloni

Brian Ostrander

John Dyett

John Niederhuber

Yumin Qiu

Paul Bunn

Raphael Pollock

Baran Sumer

Charles Balch

Alexander Eggermont

Brett Giroir

Gina Guillem Jones

Description